GU Cancers Symposium 2014 - Evaluating the safety of abiraterone acetate and docetaxel administered in combination in patients with metastatic castration-resistant prostate cancer - Poster

SAN FRANCISCO, CA USA (UroToday.com) - Presented by Scott T. Tagawa, David M. Nanus, Edwin M. Posadas, Daniel Peter Petrylak, Justine Yang Bruce, Emerson A. Lim, Weimin Peng, Raymond Scott Maul, Martha Gonzalez, and Namphuong Tran at the 2014 Genitourinary Cancers Symposium - January 30 - February 1, 2014 - San Francisco Marriott Marquis - San Francisco, California USA

gucancer 2014 Tagawa AA-plus-Docetaxel-poster thumb

Weill Cornell Medical College, New York, NY; Cedars-Sinai Medical Center, Los Angeles, CA; Yale Cancer Center, New Haven, CT; University of Wisconsin School of Medicine and Public Health, Madison, WI; Columbia University Medical Center, New York, NY; Janssen Research & Development, LLC, Los Angeles, CA; Janssen Research & Development, LLC, Raritan, NJ

 

email news signup